PRDM9 and neoplasm: As previously discussed, activation of the JAK/STAT pathway in ENKTL converts the histone methyltransferase EZH2 into a non-canonical transcriptional activator of genes involved in cell proliferation, with inhibition of JAK3 decreasing EZH2 expression and decreasing ENKTL tumor growth [34,38].